WNT5A and colorectal cancer: In our first example, we use binding energy calculations to uncover that mutations in our data set do not occur in the regions of the protein responsible for binding FZD, and in our second example, we focus on a single WNT (human WNT5A) to show that mutations in colorectal cancer are expected to alter the ligand conformational flexibility.